Innoviva Inc
NASDAQ:INVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innoviva Inc
NASDAQ:INVA
|
US |
|
M
|
Murata Manufacturing Co Ltd
XMUN:MUR1
|
JP |
|
B
|
Box-Pak (Malaysia) Bhd
KLSE:BOXPAK
|
MY |
|
Virbac SA
F:V16
|
FR |
|
V
|
Varroc Engineering Ltd
NSE:VARROC
|
IN |
|
V
|
VF Corp
F:VFP
|
US |
|
I
|
Ingersoll Rand Inc
F:5GD
|
US |
|
H
|
Hon Hai Precision Industry Co Ltd
LSE:HHPG
|
TW |
|
IAMGOLD Corp
TSX:IMG
|
CA |
|
Kadestone Capital Corp
XTSX:KDSX
|
CA |
Intrinsic Value
Is INVA undervalued or overvalued?
See the intrinsic value estimate for
Innoviva Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Innoviva Does
Innoviva is a healthcare royalty company. Its main business is owning rights to receive payments on medicines developed and sold by other companies, especially inhaled treatments for lung diseases. Instead of running a big drug sales force, Innoviva sits further up the value chain and collects income when partner products sell well.
- Headquarters
- United States of America US
- Employees
- 159
- IPO date
- Oct 5, 2004
Revenue & Expenses Breakdown
Innoviva Inc
Earnings Waterfall
Innoviva Inc
The intrinsic value for
Innoviva Inc (INVA) under the Base Case is hidden USD.
Compared with the current market price of 21.355 USD, the stock appears hidden.